ID: ALA4172284

Max Phase: Preclinical

Molecular Formula: C17H14N6O

Molecular Weight: 318.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc2[nH]ncc2cc1-c1cccc2c(N)c(C(N)=O)nnc12

Standard InChI:  InChI=1S/C17H14N6O/c1-8-5-13-9(7-20-21-13)6-12(8)10-3-2-4-11-14(18)16(17(19)24)23-22-15(10)11/h2-7H,1H3,(H2,18,22)(H2,19,24)(H,20,21)

Standard InChI Key:  IRMJEKARXQRXOY-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase TEC 1891 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase BMX 1995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase BTK 8973 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.34Molecular Weight (Monoisotopic): 318.1229AlogP: 2.16#Rotatable Bonds: 2
Polar Surface Area: 123.57Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.72CX Basic pKa: 3.90CX LogP: 1.69CX LogD: 1.69
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.52Np Likeness Score: -1.19

References

1. Liang C, Tian D, Ren X, Ding S, Jia M, Xin M, Thareja S..  (2018)  The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.,  151  [PMID:29631132] [10.1016/j.ejmech.2018.03.062]

Source